These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

422 related articles for article (PubMed ID: 29312658)

  • 1. Economic burden of nosocomial infections caused by vancomycin-resistant enterococci.
    Puchter L; Chaberny IF; Schwab F; Vonberg RP; Bange FC; Ebadi E
    Antimicrob Resist Infect Control; 2018; 7():1. PubMed ID: 29312658
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The importance of adjusting for enterococcus species when assessing the burden of vancomycin resistance: a cohort study including over 1000 cases of enterococcal bloodstream infections.
    Kramer TS; Remschmidt C; Werner S; Behnke M; Schwab F; Werner G; Gastmeier P; Leistner R
    Antimicrob Resist Infect Control; 2018; 7():133. PubMed ID: 30459945
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reduction of nosocomial bloodstream infections and nosocomial vancomycin-resistant Enterococcus faecium on an intensive care unit after introduction of antiseptic octenidine-based bathing.
    Messler S; Klare I; Wappler F; Werner G; Ligges U; Sakka SG; Mattner F
    J Hosp Infect; 2019 Mar; 101(3):264-271. PubMed ID: 30408504
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Continuous increase of vancomycin resistance in enterococci causing nosocomial infections in Germany - 10 years of surveillance.
    Remschmidt C; Schröder C; Behnke M; Gastmeier P; Geffers C; Kramer TS
    Antimicrob Resist Infect Control; 2018; 7():54. PubMed ID: 29760912
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A prospective study to determine whether cover gowns in addition to gloves decrease nosocomial transmission of vancomycin-resistant enterococci in an intensive care unit.
    Srinivasan A; Song X; Ross T; Merz W; Brower R; Perl TM
    Infect Control Hosp Epidemiol; 2002 Aug; 23(8):424-8. PubMed ID: 12186206
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Proactive infection control measures to prevent nosocomial transmission of vancomycin-resistant enterococci in Hong Kong.
    Cheng VC; Tai JW; Chen JH; So SY; Ng WC; Hung IF; Leung SS; Wong SC; Chan TC; Chan FH; Ho PL; Yuen KY
    J Formos Med Assoc; 2014 Oct; 113(10):734-41. PubMed ID: 24796821
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The local hospital milieu and healthcare-associated vancomycin-resistant enterococcus acquisition.
    Zhou MJ; Li J; Salmasian H; Zachariah P; Yang YX; Freedberg DE
    J Hosp Infect; 2019 Jan; 101(1):69-75. PubMed ID: 30026006
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Incidence and Outcomes Associated With Infections Caused by Vancomycin-Resistant Enterococci in the United States: Systematic Literature Review and Meta-Analysis.
    Chiang HY; Perencevich EN; Nair R; Nelson RE; Samore M; Khader K; Chorazy ML; Herwaldt LA; Blevins A; Ward MA; Schweizer ML
    Infect Control Hosp Epidemiol; 2017 Feb; 38(2):203-215. PubMed ID: 27825401
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of environmental contamination as a risk factor for acquisition of vancomycin-resistant enterococci in patients treated in a medical intensive care unit.
    Martínez JA; Ruthazer R; Hansjosten K; Barefoot L; Snydman DR
    Arch Intern Med; 2003 Sep; 163(16):1905-12. PubMed ID: 12963563
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of subclinical transmission of vancomycin-resistant enterococcus within an intensive care unit in Taiwan.
    Lee SC; Lee CW; Shih TC; See LC; Chu CM; Liu YC
    J Microbiol Immunol Infect; 2016 Oct; 49(5):749-759. PubMed ID: 27156242
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Horizontal infection prevention measures and a risk-managed approach to vancomycin-resistant enterococci: An evaluation.
    Bryce E; Grant J; Scharf S; Dempster L; Lau TT; Laing F; Shajari S; Forrester L
    Am J Infect Control; 2015 Nov; 43(11):1238-43. PubMed ID: 26190379
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Risk Factors, Costs, and Survival Analysis of Invasive VRE Infections at a Medical Center in Eastern Taiwan.
    Jiang HL; Zhou Z; Wang LS; Fang Y; Li YH; Chu CI
    Int J Infect Dis; 2017 Jan; 54():18-24. PubMed ID: 27836794
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Determining the clinical significance of co-colonization of vancomycin-resistant enterococci and methicillin-resistant Staphylococcus aureus in the intestinal tracts of patients in intensive care units: a case-control study.
    Yoon YK; Lee MJ; Ju Y; Lee SE; Yang KS; Sohn JW; Kim MJ
    Ann Clin Microbiol Antimicrob; 2019 Oct; 18(1):28. PubMed ID: 31601221
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of vancomycin and third-generation cephalosporins on prevalence of vancomycin-resistant enterococci in 126 U.S. adult intensive care units.
    Fridkin SK; Edwards JR; Courval JM; Hill H; Tenover FC; Lawton R; Gaynes RP; McGowan JE;
    Ann Intern Med; 2001 Aug; 135(3):175-83. PubMed ID: 11487484
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Defining the Role of the Environment in the Emergence and Persistence of vanA Vancomycin-Resistant Enterococcus (VRE) in an Intensive Care Unit: A Molecular Epidemiological Study.
    Lee AS; White E; Monahan LG; Jensen SO; Chan R; van Hal SJ
    Infect Control Hosp Epidemiol; 2018 Jun; 39(6):668-675. PubMed ID: 29611491
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Risk factors for enterococcal infection and colonization by vancomycin-resistant enterococci in critically ill patients.
    Papadimitriou-Olivgeris M; Drougka E; Fligou F; Kolonitsiou F; Liakopoulos A; Dodou V; Anastassiou ED; Petinaki E; Marangos M; Filos KS; Spiliopoulou I
    Infection; 2014 Dec; 42(6):1013-22. PubMed ID: 25143193
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dramatic increase in vancomycin-resistant enterococci in Germany.
    Gastmeier P; Schröder C; Behnke M; Meyer E; Geffers C
    J Antimicrob Chemother; 2014 Jun; 69(6):1660-4. PubMed ID: 24615816
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Factors contributing to vancomycin-resistant Enterococcus spp. horizontal transmission events: exploration of the role of antibacterial consumption.
    Gilbert EM; Zembower TR; Rhodes NJ; Qi C; Reiner S; Malczynski M; Scheetz MH
    Diagn Microbiol Infect Dis; 2017 Sep; 89(1):72-77. PubMed ID: 28669681
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative Epidemiology of Vancomycin-Resistant Enterococci Colonization in an Acute-Care Hospital and Its Affiliated Intermediate- and Long-Term Care Facilities in Singapore.
    Tan D; Htun HL; Koh J; Kanagasabai K; Lim JW; Hon PY; Ang B; Chow A
    Antimicrob Agents Chemother; 2018 Dec; 62(12):. PubMed ID: 30224534
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The risk of developing a vancomycin-resistant Enterococcus bloodstream infection for colonized patients.
    Salgado CD
    Am J Infect Control; 2008 Dec; 36(10):S175.e5-8. PubMed ID: 19084155
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.